Abstract
Background: Prostate cancer represents the second most frequently diagnosed malignancy in men, and is considered as the fifth leading cause of death from cancer in men. The aims of this paper are shown the development of new, rapid, and clean synthetic routes toward focused libraries of such compounds is therefore of great importance to both medicinal and synthetic chemists.
Methods: The preparation of benzochromene and benzoquinoline derivatives using the Michael addition between benzylidenemalononitrile derivatives and the 1-tetralones respective, in presence of catalytic amount of piperidine, or in presence of ammonium acetate, and catalytic amount of acetic acid respectively is reported, together a studies of their activity against human prostate cancer cells PC-3 and LNCaP in vitro. Results: From a total of 56 compounds, 12 were cytotoxic, inhibiting PC-3 cell viability, and the three most active compounds were also cytotoxic to LNCaP and MatLyLu cells. An important remark is that the three compounds were significantly more toxic to cancer cells compared to non-cancer cells (HK-2 and BPH-1). Conclusion: Three compounds proved to be most active, showed cytotoxic effects in different human and non-human prostate cancer cell line. The mechanism of the antitumor activity of this structure seems to be related by inhibition of MMP-9.Keywords: Benzochromene, benzoquinoline, prostate, cancer, MMP-9.
Letters in Drug Design & Discovery
Title:Synthesis, Antiproliferative, and Antiangiogenic Activities of Benzochromene and Benzoquinoline Derivatives on Prostate Cancer in vitro
Volume: 14 Issue: 4
Author(s): Gricelda Mata, Juan Rodrigues, Neira Gamboa, Katiuska Charris, Gricela Lobo, Melina Monasterios, Milagros Avendano, Michael Lein, Klaus Jung, Claudia Abramjuk, Bianca Nitzsche, Michael Hopfner and Jaime Charris
Affiliation:
Keywords: Benzochromene, benzoquinoline, prostate, cancer, MMP-9.
Abstract: Background: Prostate cancer represents the second most frequently diagnosed malignancy in men, and is considered as the fifth leading cause of death from cancer in men. The aims of this paper are shown the development of new, rapid, and clean synthetic routes toward focused libraries of such compounds is therefore of great importance to both medicinal and synthetic chemists.
Methods: The preparation of benzochromene and benzoquinoline derivatives using the Michael addition between benzylidenemalononitrile derivatives and the 1-tetralones respective, in presence of catalytic amount of piperidine, or in presence of ammonium acetate, and catalytic amount of acetic acid respectively is reported, together a studies of their activity against human prostate cancer cells PC-3 and LNCaP in vitro. Results: From a total of 56 compounds, 12 were cytotoxic, inhibiting PC-3 cell viability, and the three most active compounds were also cytotoxic to LNCaP and MatLyLu cells. An important remark is that the three compounds were significantly more toxic to cancer cells compared to non-cancer cells (HK-2 and BPH-1). Conclusion: Three compounds proved to be most active, showed cytotoxic effects in different human and non-human prostate cancer cell line. The mechanism of the antitumor activity of this structure seems to be related by inhibition of MMP-9.Export Options
About this article
Cite this article as:
Mata Gricelda, Rodrigues Juan, Gamboa Neira, Charris Katiuska, Lobo Gricela, Monasterios Melina, Avendano Milagros, Lein Michael, Jung Klaus, Abramjuk Claudia, Nitzsche Bianca, Hopfner Michael and Charris Jaime, Synthesis, Antiproliferative, and Antiangiogenic Activities of Benzochromene and Benzoquinoline Derivatives on Prostate Cancer in vitro, Letters in Drug Design & Discovery 2017; 14 (4) . https://dx.doi.org/10.2174/1570180814666161118163844
DOI https://dx.doi.org/10.2174/1570180814666161118163844 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy Inhibitory Role of Resveratrol in the Development of Profibrogenesis and Fibrosis Mechanisms
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Kallikrein-Kinin System Mediated Inflammation in Alzheimers Disease In Vivo
Current Alzheimer Research Nanodiamonds as a New Horizon for Pharmaceutical and Biomedical Applications
Current Drug Delivery Nuclear Hormone Receptors and Female Reproduction
Current Molecular Medicine Ultrasound-Triggered Immunotherapy for Cancer Treatment: An Update
Current Protein & Peptide Science LPTS: A Novel Tumor Suppressor Gene and a Promising Drug Target for Cancer Intervention
Recent Patents on Anti-Cancer Drug Discovery Involvement of the P2X7 Purinergic Receptor in Inflammation: An Update of Antagonists Series Since 2009 and their Promising Therapeutic Potential
Current Medicinal Chemistry Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer
Anti-Cancer Agents in Medicinal Chemistry Anti-Inflammatory Drugs and Prediction of New Structures by Comparative Analysis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Genetic Regulation of ADPRT/PARP-1 in Aging and Cancer Susceptibility
Current Pharmacogenomics The Ubiquitin-Proteasome System and Proteasome Inhibitors in Central Nervous System Diseases
Cardiovascular & Hematological Disorders-Drug Targets Cell Penetrating Peptides for Tumor Targeting
Current Pharmaceutical Biotechnology Surgical Complications of Hyperglycaemia
Current Diabetes Reviews Pharmacoperones as a New Therapeutic Approach: In Vitro Identification and In vivo Validation of Bioactive Molecules
Current Drug Targets The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Pluripotency Crossroads: Junction of Transcription Factors, Epigenetic Mechanisms, MicroRNAs, and Long Non-coding RNAs
Current Stem Cell Research & Therapy Epigenetic control of cardiovascular health by nutritional polyphenols involves multiple chromatin-modifying writer-reader-eraser proteins
Current Topics in Medicinal Chemistry Modulation of Histone Acetylation by Garlic Sulfur Compounds
Anti-Cancer Agents in Medicinal Chemistry Ultrasound Therapeutics– A Review
Current Medical Imaging